
An FDA committee has passed a contentious vote recommending by a slim majority for the withdrawal of existing approval of …

AMAG Pharmaceuticals’ Makena (hydroxyprogesterone caproate) has failed to meet its co-primary endpoints in a trial of patients with a history …

A study by the UT Southwestern Medical Center has found that the synthetic progestogen hormone 17-alpha hydroxyprogesterone caproate (17-OHPC), a …
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation

